Much has changed since the previous guidance was issued in 2008, in particular, the incidence of MRSA in UK hospitals has fallen markedly as well as new anti-staphylococcal antibiotics becoming available. An update to the national MRSA treatment guideline in light of these changes is therefore required.
Updating these national guidelines was a joint initiative of British Society for Antimicrobial Stewardship (BSAC), British Infection Association (BIA), Healthcare Infection Society (HIS) and Infection Prevention Society (IPS). However, BSAC and BIA alone were involved in the production of this guideline. A separate guideline updating recommendations for infection prevention and control of MRSA will be developed by HIS and IPS.